Welcome! If you have a coupon code, click here to apply it. Apply
stock
Lineage Cell Therapeutics Inc
NYSE MKT | LCTX
1.02
USD
0.00 ( 0.00%)
AT CLOSE (AS OF Jun 25, 2025)
$247M
MARKET CAP
-
P/E Ratio
-0.07
EPS
$1.2
52 Week High
$0.37
52 Week Low
LIFE SCIENCES
Sector
LCTX Chart
Recent Chart
Price Action
1D
Candles
Trade Smarter
Automate your trading workflow with powerful tools — built for serious traders.
LCTX Technicals
LCTX Earnings
Yearly Income Statement (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Gross Profit | $9.2M |
| Total Revenue | $9.5M |
| Cost Of Revenue | $334K |
| Costof Goods And Services Sold | $334K |
| Operating Income | -$21M |
| Selling General And Administrative | $18M |
| Research And Development | $12M |
| Operating Expenses | $31M |
| Investment Income Net | - |
| Net Interest Income | $1.7M |
| Interest Income | $1.7M |
| Interest Expense | - |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $609K |
| Income Before Tax | -$19M |
| Income Tax Expense | $27K |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$19M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$21M |
| Ebitda | -$21M |
| Net Income | -$19M |
Revenue & Profitability
Earnings Performance
LCTX Financials
yearly Balance Sheet (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Total Assets | $113M |
| Total Current Assets | $51M |
| Cash And Cash Equivalents At Carrying Value | $46M |
| Cash And Short Term Investments | $46M |
| Inventory | - |
| Current Net Receivables | $638K |
| Total Non Current Assets | $62M |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | $47M |
| Intangible Assets Excluding Goodwill | $47M |
| Goodwill | $11M |
| Investments | - |
| Long Term Investments | - |
| Short Term Investments | $2M |
| Other Current Assets | $2.6M |
| Other Non Current Assets | - |
| Total Liabilities | $36M |
| Total Current Liabilities | $14M |
| Current Accounts Payable | $1.2M |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $2.3M |
| Total Non Current Liabilities | $22M |
| Capital Lease Obligations | $2.5M |
| Long Term Debt | - |
| Current Long Term Debt | - |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $2.5M |
| Other Current Liabilities | $2.4M |
| Other Non Current Liabilities | - |
| Total Shareholder Equity | $78M |
| Treasury Stock | - |
| Retained Earnings | -$403M |
| Common Stock | $485M |
| Common Stock Shares Outstanding | $200M |
yearly Cash Flow (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Operating Cashflow | -$23M |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $609K |
| Capital Expenditures | $565K |
| Change In Receivables | - |
| Change In Inventory | - |
| Profit Loss | - |
| Cashflow From Investment | - |
| Cashflow From Financing | $36M |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | - |
| Dividend Payout Common Stock | - |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | -$23K |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | -$19M |
yearly Income Statement (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Gross Profit | $9.2M |
| Total Revenue | $9.5M |
| Cost Of Revenue | $334K |
| Costof Goods And Services Sold | $334K |
| Operating Income | -$21M |
| Selling General And Administrative | $18M |
| Research And Development | $12M |
| Operating Expenses | $31M |
| Investment Income Net | - |
| Net Interest Income | $1.7M |
| Interest Income | $1.7M |
| Interest Expense | - |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $609K |
| Income Before Tax | -$19M |
| Income Tax Expense | $27K |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$19M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$21M |
| Ebitda | -$21M |
| Net Income | -$19M |
Dividends
| Field | Value |
|---|---|
| Ex Dividend Date | 2016-01-04 |
| Declaration Date | None |
| Record Date | None |
| Payment Date | None |
| Amount | 0.3125 |
LCTX Profile
Lineage Cell Therapeutics Inc Profile
Sector: LIFE SCIENCES
Industry: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing therapeutics for the treatment of degenerative diseases in the United States and internationally. The company is headquartered in Carlsbad, California.
PSTV 67.06%
$0.3124
ICU 16.46%
$0.4188
GNLN -19.10%
$0.0072
HCTI -6.67%
$0.0308
NVDA 3.91%
$153.6818
QS 32.47%
$5.7358
DNN -3.33%
$1.74
VOR 51.52%
$0.482
LCID -0.92%
$2.15
TSLA -4.56%
$324.9486
SRFM 10.99%
$3.9955
SONM 7.59%
$1.205
AXDX -61.36%
$0.034
VHAI -25.00%
$0.0004
SMCI 8.13%
$46.3217
F -2.24%
$10.49
BP 1.54%
$30.29
SAFX
36.55%
$2.335
AMD 3.26%
$142.94
ABEV -3.15%
$2.3243
SOFI 1.20%
$16.0399
LYT -16.78%
$0.0982
BB 14.09%
$4.9399
JWN 0.08%
$24.66
BLNE -6.37%
$1.3296
HIMS -0.88%
$42.57
PLTR -0.91%
$141.9227
SNAP 5.18%
$8.32
INTC -1.80%
$22.145
CRCL
-8.08%
$204.665
WULF 0.91%
$3.875
PLUG -4.32%
$1.1099
ONDS 0.94%
$1.605
HOOD 0.68%
$82.565
DFS -0.21%
$200.05
BTE 0.26%
$1.8147
QXO -6.09%
$22.0771
MARA 0.13%
$14.899
CUTR -10.19%
$0.0969
NVTS -1.77%
$7.2199
AAL -3.39%
$10.985
RIG -2.04%
$2.645
WBD -0.02%
$10.898
NCNA -3.98%
$0.0869
BTG 0.70%
$3.585
RIOT -1.15%
$9.905
VALE -1.51%
$9.0712
APLD -3.73%
$9.935
ACHR -5.36%
$10.155
AAPL 0.30%
$200.9109
CLSK 5.83%
$10.625
CAN -5.45%
$0.6141
GRAB -2.13%
$4.6388
SOUN -0.97%
$9.725
COIN 1.49%
$349.9712
GOOGL 1.84%
$169.845
TMC 16.26%
$7.685
STLA 2.87%
$9.865
WLGS 5.37%
$0.051
NKTR 22.90%
$30.05
AFMD -34.95%
$0.1815
NAAS 12.81%
$0.8664
GCTK 33.66%
$8.3
QBTS -2.64%
$14.575
ITUB -3.09%
$6.58
LDTC -19.74%
$0.1525
ULY 78.18%
$8.0019
SHEL -1.05%
$69.4
RZLV 5.56%
$2.9346
IREN 3.86%
$11.985
RGTI 0.83%
$11.595
AG 1.13%
$8.1507
QSI 11.44%
$2.095
GNS 5.93%
$0.7383
CIFR -0.13%
$3.845
BAC 0.61%
$46.945
AMZN -0.66%
$211.37
ADIL 7.02%
$0.2454
MLGO 5.48%
$0.6119
BBD -0.99%
$3
ASTS -5.35%
$50.3729
NIO -1.09%
$3.4619
RKLB -2.42%
$32.65
KEY 1.58%
$16.75
MU -0.82%
$126.865
MULN -11.30%
$0.8959
CCL -1.51%
$25.3128
GOOG 1.88%
$170.89
PCG -1.85%
$13.8987
RXRX -2.01%
$5.115
IBO 15.48%
$0.97
EQX 1.48%
$5.916
PBR -0.93%
$12.2952
IQ -3.37%
$1.72
NGD 0.55%
$4.8767
FLG -4.69%
$10.5988
HL 0.26%
$5.815
PTN -44.65%
$0.0941
SBET 10.46%
$10.67
PFE -0.12%
$24.2802
PSTV 67.06%
$0.3124
ICU 16.46%
$0.4188
GNLN -19.10%
$0.0072
HCTI -6.67%
$0.0308
NVDA 3.91%
$153.6818
QS 32.47%
$5.7358
DNN -3.33%
$1.74
VOR 51.52%
$0.482
LCID -0.92%
$2.15
TSLA -4.56%
$324.9486
SRFM 10.99%
$3.9955
SONM 7.59%
$1.205
AXDX -61.36%
$0.034
VHAI -25.00%
$0.0004
SMCI 8.13%
$46.3217
F -2.24%
$10.49
BP 1.54%
$30.29
SAFX
36.55%
$2.335
AMD 3.26%
$142.94
ABEV -3.15%
$2.3243
SOFI 1.20%
$16.0399
LYT -16.78%
$0.0982
BB 14.09%
$4.9399
JWN 0.08%
$24.66
BLNE -6.37%
$1.3296
HIMS -0.88%
$42.57
PLTR -0.91%
$141.9227
SNAP 5.18%
$8.32
INTC -1.80%
$22.145
CRCL
-8.08%
$204.665
WULF 0.91%
$3.875
PLUG -4.32%
$1.1099
ONDS 0.94%
$1.605
HOOD 0.68%
$82.565
DFS -0.21%
$200.05
BTE 0.26%
$1.8147
QXO -6.09%
$22.0771
MARA 0.13%
$14.899
CUTR -10.19%
$0.0969
NVTS -1.77%
$7.2199
AAL -3.39%
$10.985
RIG -2.04%
$2.645
WBD -0.02%
$10.898
NCNA -3.98%
$0.0869
BTG 0.70%
$3.585
RIOT -1.15%
$9.905
VALE -1.51%
$9.0712
APLD -3.73%
$9.935
ACHR -5.36%
$10.155
AAPL 0.30%
$200.9109
CLSK 5.83%
$10.625
CAN -5.45%
$0.6141
GRAB -2.13%
$4.6388
SOUN -0.97%
$9.725
COIN 1.49%
$349.9712
GOOGL 1.84%
$169.845
TMC 16.26%
$7.685
STLA 2.87%
$9.865
WLGS 5.37%
$0.051
NKTR 22.90%
$30.05
AFMD -34.95%
$0.1815
NAAS 12.81%
$0.8664
GCTK 33.66%
$8.3
QBTS -2.64%
$14.575
ITUB -3.09%
$6.58
LDTC -19.74%
$0.1525
ULY 78.18%
$8.0019
SHEL -1.05%
$69.4
RZLV 5.56%
$2.9346
IREN 3.86%
$11.985
RGTI 0.83%
$11.595
AG 1.13%
$8.1507
QSI 11.44%
$2.095
GNS 5.93%
$0.7383
CIFR -0.13%
$3.845
BAC 0.61%
$46.945
AMZN -0.66%
$211.37
ADIL 7.02%
$0.2454
MLGO 5.48%
$0.6119
BBD -0.99%
$3
ASTS -5.35%
$50.3729
NIO -1.09%
$3.4619
RKLB -2.42%
$32.65
KEY 1.58%
$16.75
MU -0.82%
$126.865
MULN -11.30%
$0.8959
CCL -1.51%
$25.3128
GOOG 1.88%
$170.89
PCG -1.85%
$13.8987
RXRX -2.01%
$5.115
IBO 15.48%
$0.97
EQX 1.48%
$5.916
PBR -0.93%
$12.2952
IQ -3.37%
$1.72
NGD 0.55%
$4.8767
FLG -4.69%
$10.5988
HL 0.26%
$5.815
PTN -44.65%
$0.0941
SBET 10.46%
$10.67
PFE -0.12%
$24.2802
Discover more tools and features to empower your trading
Explore FeaturesQuotes and other market data may be delayed by 15 minutes or more. Financial data is provided by financial exchanges and other content providers and may be delayed as specified by financial exchanges or other data providers. AfterPullback does not verify any data and disclaims any obligation to do so. The information contained on this website is not intended as, and shall not be understood as, financial advice. The website does not operated by attorney, accountant or financial advisor and the information contained on this website is not a substitute for financial advice from a professional who is aware of the facts and circumstances of your individual situation. Nothing available on or through this website should be understood as a recommendation that you should not consult with a financial professional to address your particular information.